Search
Huasai Biotechnology Secures Nearly RMB 100 Million in Series A Funding to Expedite Commercialization and Enhance Production Capacity of Green Synthetic Products
2026-01-05 /
Read about 0 minute
Author：小编
Helmed by Dr. Hu Zhihao and his accomplished team, Huasai Biotechnology leverages a cutting-edge synthetic biology and metabolic engineering platform. The company's core focus lies in pioneering innovative biosynthetic pathways, revamping microbial cell factories, and attaining green, efficient production of high-value products. This strategy tackles the root causes of the high energy consumption and substantial emissions linked to conventional chemical synthesis or fermentation methods.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
